Evidence map›Paper›PMID 40445972›Full record

ArticlePloS one2025

Prediction of drug-target interactions based on substructure subsequences and cross-public attention mechanism.

Haikuo Shi, Jing Hu, Xiaolong Zhang, Shuting Jin, Xin Xu

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Haikuo ShiJing Hu, School of Computer Science and Technology, Wuhan University of Science and Technology, Wuhan, Hubei, China.ORCID 0009-0008-0049-1635
Jing HuJing Hu, School of Computer Science and Technology, Wuhan University of Science and Technology, Wuhan, Hubei, China.
Xiaolong ZhangJing Hu, School of Computer Science and Technology, Wuhan University of Science and Technology, Wuhan, Hubei, China.
Shuting JinJing Hu, School of Computer Science and Technology, Wuhan University of Science and Technology, Wuhan, Hubei, China.
Xin XuJing Hu, School of Computer Science and Technology, Wuhan University of Science and Technology, Wuhan, Hubei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug-target interactions (DTIs) play a critical role in drug discovery and repurposing. Deep learning-based methods for predicting drug-target interactions are more efficient than wet-lab experiments. The extraction of original and substructural features from drugs and proteins plays a key role in enhancing the accuracy of DTI predictions, while the integration of multi-feature information and effective representation of interaction data also impact the precision of DTI forecasts. Consequently, we propose a drug-target interaction prediction model, SSCPA-DTI, based on substructural subsequences and a cross co-attention mechanism. We use drug SMILES sequences and protein sequences as inputs for the model, employing a Multi-feature information mining module (MIMM) to extract original and substructural features of DTIs. Substructural information provides detailed insights into molecular local structures, while original features enhance the model's understanding of the overall molecular architecture. Subsequently, a Cross-public attention module (CPA) is utilized to first integrate the extracted original and substructural features, then to extract interaction information between the protein and drug, addressing issues such as insufficient accuracy and weak interpretability arising from mere concatenation without interactive integration of feature information. We conducted experiments on three public datasets and demonstrated superior performance compared to baseline models.

Indexed as

Drug DiscoveryProteinsAlgorithmsData MiningDeep LearningDrug RepositioningHumansPharmaceutical PreparationsPharmaceutical PreparationsProteins

Identifiers

PMID40445972
PMCPMC12124583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.